Sutent 12.5 mg

Sunitinib (Sutent) 12.5 mg capsules are a cancer treatment medication used to target specific proteins in cancer cells. This oral medication is designed to inhibit tumor growth and is commonly prescribed for certain types of cancer.

Sunitinib (Sutent) 12.5 mg capsules are primarily used in the treatment of advanced kidney cancer (renal cell carcinoma) and gastrointestinal stromal tumors (GIST). This medication works by targeting specific proteins involved in the growth and spread of cancer cells. Patients may wonder, 'What is Sunitinib used for?' It is also used in the treatment of pancreatic neuroendocrine tumors and other types of cancer as determined by a healthcare provider.

Common effects of Sunitinib (Sutent) 12.5 mg capsules may include fatigue, nausea, diarrhea, and changes in skin color. Some users may experience appetite loss, vomiting, or hand-foot syndrome, which can cause redness, swelling, or peeling of the skin on the palms and soles. These effects can vary from person to person.

Sunitinib (Sutent) 12.5 mg capsules should be handled with care and stored as directed. It is important to follow the advice of a healthcare provider regarding administration and to report any severe or persistent side effects. This medication should not be used without medical supervision.

Sunitinib (Sutent) 12.5 mg capsules may interact with certain medications, including those metabolized by the liver's CYP3A4 enzyme. It is advisable to inform a healthcare provider about all current medications, including over-the-counter drugs and supplements, to avoid potential interactions. Alcohol consumption should be discussed with a healthcare provider.